As part of the Sativa Group PLC’s ongoing commitment to continually deliver the highest level of regulatory compliance and substantiate ‘CBD you can trust’, the Company has become a member of the Association for the Cannabinoid Industry (ACI) Novel Food consortium and it’s landmark toxicology study, which will augment the submission of it’s own Novel Food application dossier.

As part of the Sativa Group PLC’s ongoing commitment to continually deliver the highest level of regulatory compliance and substantiate ‘CBD you can trust’, the Company has become a member of the Association for the Cannabinoid Industry (ACI) Novel Food consortium and it’s landmark toxicology study, which will augment the submission of it’s own Novel Food application dossier.

Further to the Company’s news release dated September 10, 2020, Sativa wishes to provide an update on the status of the re-listing of Stillcanna Inc. (to be renamed Sativa Wellness Group Inc.) (“Stillcanna”) common shares on the Canadian Securities Exchange (the “CSE”) and the AQSE Growth Market (the “AQSE”). The Company is currently co-ordinating with Stillcanna a date of re-listing with the CSE, and continues to work diligently to fulfil the remaining conditions of re-listing.